NSI-189 Freebase
Price range: $52.46 through $125.69
Earn 52 – 126 points upon purchasing this product.
✅ 99% Purity – Third-Party Tested
🚚 Free U.S. Shipping on Orders $100+
🇺🇸 Proudly Made in the USA
⚡ Fast & Reliable Shipping
🔒 Secure Checkout Guaranteed
Full disclaimer ↓
≥99% Purity — HPLC Verified
Dual COA — HPLC + LAL Endotoxin
Unique Lot Numbers — Full Traceability
USA Manufactured & Third-Party Tested
Ships USA in 1 Business Day
QC: 2025-11-08
≥99.3% HPLC
Buy NSI-189 —
≥99% Purity + Dual COA
When you buy NSI-189 from PureRawz, every order arrives with two independent Certificates of Analysis — HPLC purity verification and an LAL endotoxin assay — traceable to a unique batch lot number. SwissChems is Iceland-based with no per-lot LAL data. AdooQ lists >99% purity but provides no endotoxin documentation. PureRawz is the USA-based, dual-COA alternative. Ships in 1 business day. No prescription required.
LAL Endotoxin Tested
Unique Lot Number
USA Manufactured
Ships in 1 Business Day
per unit · free shipping $[THRESHOLD]+
In-stock orders ship same business day — USA domestic only
Full Product Specifications
All data verifiable via lot-specific COA documents included with every order.
| Compound Name | NSI-189 (Free Base) |
| Also Known As | Amdiglurax, ALTO-100, NSI189 |
| Phosphate Salt Form | NSI-189 Phosphate (CAS 1270138-41-4) |
| IUPAC Name | (4-benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl]methanone |
| Molecular Formula (FB) | C₂₂H₂₉N₄O·HCl / C₂₂H₃₀ClN₄O |
| Molecular Weight (FB) | 366.5 g/mol (free base) |
| Molecular Formula (PO₄) | C₂₂H₃₃N₄O₅P |
| Molecular Weight (PO₄) | 464.5 g/mol |
| CAS (Free Base) | 1270138-40-3 |
| CAS (Phosphate) | 1270138-41-4 |
| PubChem CID | 44,231,552 (free base) |
| Purity (HPLC) | ≥99% — third-party verified per lot |
| Endotoxin (LAL) | Tested — COA included per lot |
| Physical Appearance | White to off-white powder |
| Solubility | DMSO (free base); water/PBS (phosphate form) |
| Storage | −20 °C, desiccated, protected from light |
| Shelf Life | 24–36 months under proper conditions |
| Lot Traceability | Unique lot number — every unit, every batch |
| Manufacturing | USA (domestic synthesis) |
| Testing | Independent third-party laboratory |
| Shipping | 1 business day · USA domestic only |
| Intended Use | In-vitro laboratory research only |
Why PureRawz Provides a Dual COA — And Why It Matters for NSI-189 Research
SwissChems posts periodic lab images — not per-lot LAL data. AdooQ lists >99% HPLC but provides no endotoxin documentation. PureRawz issues two separate, lot-specific COAs on every batch — because NSI-189's primary research applications (hippocampal neurogenesis assays, cell-viability studies, BDNF quantification) are exactly the assays endotoxin contamination corrupts silently.
HPLC Purity Certificate
High-Performance Liquid Chromatography separates and quantifies every molecular species in the sample. PureRawz NSI-189 consistently measures ≥99% purity per lot release. The full chromatogram with peak integration is available in the COA PDF, confirming chemical identity and ruling out synthesis by-products, degradation impurities, or residual solvents. This is what most suppliers stop at.
≥99% purity confirmed per lot
LAL Endotoxin Assay Certificate
The Limulus Amebocyte Lysate (LAL) assay detects bacterial lipopolysaccharides (LPS) that HPLC cannot identify. This is critical for NSI-189 research: neurogenesis studies rely on Ki67 proliferation assays and BDNF ELISA — both catastrophically confounded by trace LPS activating TLR4 on macrophages and glia, generating false neuroinflammatory signals that mask or mimic NSI-189's actual effects. Neither SwissChems nor AdooQ provides this documentation per lot.
LAL endotoxin tested — per lot
Both COA documents are lot-number-specific. Download from the product page or retrieve via officialpurerawz.us/verify.
What Is NSI-189?
NSI-189 is a benzylpiperazine-aminopyridine small molecule discovered through systematic screening of a chemical library against an in-vitro model of hippocampal neurogenesis using a stable cell line of human foetal hippocampal neural stem cells (US Patent No. 8,293,488). It was originally developed by Neuralstem Inc. and is now advanced as Amdiglurax (ALTO-100) by Alto Neuroscience for major depressive disorder, bipolar depression, and PTSD.
What makes NSI-189 a distinctive research tool is its non-monoaminergic mechanism. Screening against 52 neurotransmitter-related receptors, ion channels, and enzymes — and separately against 900 kinases — was negative. NSI-189 does not interact with serotonin, norepinephrine, or dopamine transporters or receptors. This profile makes it exceptionally useful for researchers studying neurogenesis and neuroplasticity independently of classical monoamine pathway confounders.
In rodent models, NSI-189 dose-dependently increases hippocampal volume at 30 mg/kg, with effects confined to the dentate gyrus of the hippocampus and the subventricular zone (SVZ) — the two known neurogenic regions in the adult CNS. A 20% increase in hippocampal volume has been documented in healthy young adult mice. Phase 2 clinical data (2023, Alto Neuroscience) reported approximately 46% greater improvement in depressive symptoms in patients with a specific cognitive biomarker profile, supporting continued clinical development.
PureRawz sells NSI-189 exclusively as an in-vitro research reagent. All preclinical findings cited here arise from animal or cell-based models and must not be interpreted as clinical outcomes.
Mechanism of Action — Six Research Pathways
All findings are from in-vitro or animal studies only. NSI-189's exact molecular target remains under investigation — its non-monoaminergic profile distinguishes it from all existing antidepressant compound classes.
NSI-189 stimulates neurogenesis of human hippocampus-derived neural stem cells in vitro and in mouse hippocampus in vivo. Effects are confined to the dentate gyrus and subventricular zone — the only two known neurogenic regions in the adult CNS. In healthy young adult mice, oral NSI-189 produces a dose-dependent 20% increase in hippocampal volume at 30 mg/kg.
Fava et al., PMC 2016 [1]; Neuralstem IND data
In vitro studies in rat hippocampal neurons exposed to OGD (oxygen-glucose deprivation) showed NSI-189 significantly upregulates BDNF and SCF (stem cell factor) in conditioned media. Antibody blocking of both BDNF and SCF suppressed NSI-189-mediated rescue of cell viability against OGD — directly implicating neurotrophic factor upregulation as a core mechanism.
Tajiri et al., J Cell Physiol 2017 [2]
In a mouse model of Angelman Syndrome, NSI-189 treatment was associated with activation of TrkB and Akt signalling pathways, which require DNA translation and protein synthesis. LTP (long-term potentiation) was enhanced in hippocampal slices in a time- and dose-dependent manner, reversing impairments in both cognitive and motor function readouts.
Liu et al., Neuropharmacology 2019 [3]
NSI-189 enhances theta-burst stimulation-induced LTP in acute hippocampal slices from both wild-type and disease-model mice in a dose-dependent fashion. This synaptic plasticity enhancement is associated with increased MAP2 immunoreactivity and neurite outgrowth in treated tissue — structural correlates of improved connectivity in research models.
Liu et al., Neuropharmacology 2019 [3]
In rat stroke models (middle cerebral artery occlusion), oral NSI-189 significantly attenuated OGD/R-mediated hippocampal cell death, increased Ki67 (proliferation marker) and MAP2 expression, and upregulated VEGF, GDNF, BDNF, and SCF in treated cells. NSI-189 stimulated active remodelling of the stroke brain beyond the standard 6-hour therapeutic window.
Tajiri et al., J Cell Physiol 2017 [2]
In type 1 and type 2 diabetic mouse models (db/db), oral NSI-189 prevented multiple indices of peripheral and central neuropathy, restored synaptic markers (NeuN, PSD95, synaptophysin), protected long-term memory, and halted established neuropathy progression. BDNF protein levels were restored to control levels in the hippocampus — linking the neurogenic mechanism to metabolic neuropathy models.
Saleh et al., Diabetes 2019 [4]
Batch Traceability — Our Public Lot Verification Portal
SwissChems posts shared lab images on their website — not per-lot documents for your specific vial. AdooQ provides no batch-level public access at all. PureRawz does both — because your research depends on knowing exactly what you received.
Every unit is traceable to a specific, independently tested batch.
Our lot numbering system encodes the compound code, synthesis batch number, and QC release date. Every lot is indexed in our public verification portal — enter the lot number from your order at officialpurerawz.us/verify and retrieve:
- The HPLC purity COA PDF for your exact batch
- The LAL endotoxin COA PDF for your exact batch
- The name of the independent third-party testing laboratory
- The QC release date and synthesis batch ID
- Documentation suitable for IRB submissions and publication methodology sections
NS-2025-0174
Verify at /verify →
PureRawz vs. Competitors — NSI-189 Side-by-Side
Based on publicly available supplier information as of April 2026.
| Feature | PureRawz ✦ | SwissChems | AdooQ |
|---|---|---|---|
| Purity Standard | ≥99% HPLC | Not stated per lot | >99% HPLC (listed) |
| HPLC Purity COA | ✔ Per lot — downloadable PDF | Shared lab images only | ✔ Listed on page |
| LAL Endotoxin COA | ✔ Per lot — full assay | ✗ Not provided | ✗ Not provided |
| Unique Lot Number Per Unit | ✔ Every unit | ✗ Not mentioned | ✗ Not mentioned |
| Public Lot Verification Portal | ✔ officialpurerawz.us/verify | ✗ | ✗ |
| USA Based / USA Shipping | ✔ Domestic USA only | ✗ Iceland-based (.is domain) | ✗ Global — not USA-based |
| Ships in 1 Business Day | ✔ | ✗ International transit | ✗ International transit |
| No Prescription Required | ✔ | ✔ | ✔ |
| Trust Badge Strip on Page | ✔ 5 badges | 2 basic badges | ✗ None |
| FAQ Section (Schema Rich Results) | ✔ 10 Q&As | ✗ | ✗ |
| PubMed-Linked References on Page | ✔ 5 cited | ✗ None | ✗ None |
| Free Base + Phosphate Options | ✔ [confirm your variants] | Phosphate only | ✔ Both listed |
| HPLC Refund Guarantee | ✔ | ✔ | ✗ Not stated |
✦ PureRawz. Data from publicly available pages, April 2026. Subject to change.
Researchers Studying NSI-189 Also Explore
NSI-189 Research FAQ
For research and educational purposes only. Nothing here constitutes medical advice.
References
- Fava M et al. A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. Mol Psychiatry. 2016;21(10):1372–1380. PMC5030464
- Tajiri N et al. NSI-189, a small molecule with neurogenic properties, exerts behavioral, and neurostructural benefits in stroke rats. J Cell Physiol. 2017;232(10):2731–2740. PMID: 28181668
- Liu Y et al. Enhancement of synaptic plasticity and reversal of impairments in motor and cognitive functions in a mouse model of Angelman Syndrome by NSI-189. Neuropharmacology. 2019;144:337–344. doi:10.1016/j.neuropharm.2018.10.020
- Saleh A et al. Amelioration of Both Central and Peripheral Neuropathy in Mouse Models of Type 1 and Type 2 Diabetes by the Neurogenic Molecule NSI-189. Diabetes. 2019;68(11):2143–2154. PMID: 31492662
- McIntyre RS et al. A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder. Mol Psychiatry. 2019;24(11):1701–1710. doi:10.1038/s41380-018-0334-8
NSI-189 Freebase
NSI-189 Freebase is a premium nootropic research compound commonly explored for neurogenesis studies, cognitive enhancement, mood support, and advanced laboratory applications.
Browse related Purerawz products and trusted scientific references below.
Related Products
- Buy NSI-189 – neurogenesis and cognitive research
- Buy Semax – focus and memory support studies
- Buy Selank – mood and nootropic support research
- Buy Bromantane – advanced cognitive performance support
- Buy Epithalon – longevity and peptide research
- Buy MK-677 – recovery and growth support research
Research References
-
PubMed Research Database
– scientific studies and published research -
National Center for Biotechnology Information (NCBI)
– biomedical and research resources -
U.S. Food and Drug Administration
– regulatory and compliance reference
Additional information
| Attributes | Powder 1g, Capsule 40mg per capsule/60ct/2.4g, Liquid 30ml/33mg per ml/1000mg |
|---|





Reviews
There are no reviews yet.